Concepedia

Qiang Wang

QW

Statistics

Publications

14

Citations

613

H-Index

12

Active since

1988

Affiliations

Shanghai Medical College of Fudan University(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Cornell University

Qiang Wang is an author at Shanghai Medical College of Fudan University specializing in medicine, neurophysiology, and pharmacology.

Publications per year

1988–2025

14

Publications

14

Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Joachim von Pawel, Silvia Novello et al. · Journal of Clinical Oncology · 2015 · 260 citations · Full text

Medicine, Oncology, Pharmacology +16

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

Hans Gelderblom, Andrew J. Wagner, William D. Tap et al. · Cancer · 2020 · 69 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors

James H. Lewis, Hans Gelderblom, Michiel A. J. van de Sande et al. · The Oncologist · 2020 · 60 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of Preoperative Risk Factor for Converting Laparoscopic to Open Cholecystectomy: A Meta-Analysis.

Teng Yang, Lin Guo, Qiang Wang · PubMed · 2014 · 56 citations

Medicine, Surgery, General Surgery +11

Fibroblast growth factor 10 alleviates particulate matter-induced lung injury by inhibiting the HMGB1-TLR4 pathway

Linjing Liu, Chenjian Song, Jingli Li et al. · Aging · 2020 · 28 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

1–5 of 14